Solid Tumor, Unspecified, Adult

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

Gustave Roussy Cancer Profiling

Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors

Psychotherapy Intervention for Latinos With Adv Cancer

Psychotherapy Intervention for Latinos With Advanced Cancer

The Safety and Dosimetry Study of 177Lu-LNC1004 Injection

Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies

68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors

Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein

Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair